Europe
Fridtjof Helemann will leave the company on 31 March 2019, upon reaching retirement age.
CARMAT today announced an update on its clinical progress and recent developments, as well as its cash position at December 31, 2018.
MyCareLink Heart(TM) Mobile App Allows Pacemaker Patients to Easily Stay Connected with Their Clinics
Closes acquisition of Orphan Drug Designation for betahistine for the treatment of obesity associated with Prader-Willi syndrome (PWS)
The effects of linoleic acid on the human body are largely dependent on genes, a new study from the University of Eastern Finland shows. Linoleic acid is an essential fatty acid.
Patients could benefit from improved care and outcomes thanks to new research guidance developed as part of a University of Stirling-led study.
CarTher today announces it has secured approval from the French National Agency for Medicines and Health Products Safety (ANSM) to start a Phase I-II clinical trial of its SonoCloud-9 device in the treatment of recurrent glioblastoma.
Joanna Smart to lead VivoPlex through next phase of growth
Minoryx Therapeutics opens Belgian subsidiary that will lead important development activities
In 2018 alone, mergers and acquisitions (M&A) activity among the life sciences industry totaled US$198B according to the 2019 EY M&A Firepower Report. The report continues on to state that “Life sciences M&A in 2018 was strong but failed to meet market expectations as companies focused on portfolio optimization.”
PRESS RELEASES